Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster.

Overview

authors

Silva, Almir Ribeiro da

Villas-Boas, Lucy Santos

Paula, Anderson Vicente de

Tozetto-Mendoza, Tania Regina

Honorato, Layla

Witkin, Steven S.
Mendes-Correa, Maria Cassia

publication date

June 17, 2022

published in

Revista do Instituto de Medicina Tropical de Sao Paulo Journal

Research

keywords

Antibodies, Neutralizing
COVID-19

Identity

PubMed Central ID

PMC9208660

Scopus Document Identifier

85132276298

Digital Object Identifier (DOI)

10.1590/S1678-9946202264043

PubMed ID

35730869

Additional Document Info

has global citation frequency

1

volume

64